These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1794413)

  • 1. N-methyl-D-aspartate increases the excitability of nigrostriatal dopamine terminals.
    Overton P; Clark D
    Eur J Pharmacol; 1991 Aug; 201(1):117-20. PubMed ID: 1794413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evidence that intrastriatally administered N-methyl-D-aspartate augments striatal dopamine tone in the rat.
    Overton P; Clark D
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):1-14. PubMed ID: 1540303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids.
    Keefe KA; Sved AF; Zigmond MJ; Abercrombie ED
    J Neurochem; 1993 Nov; 61(5):1943-52. PubMed ID: 7901337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat.
    Westerink BH; Santiago M; De Vries JB
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):523-9. PubMed ID: 1528270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals.
    Johnson KM; Jeng YJ
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1416-21. PubMed ID: 1685693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation.
    Garcia-Munoz M; Young SJ; Groves PM
    Brain Res; 1991 Jun; 551(1-2):207-15. PubMed ID: 1680522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists.
    Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA
    Brain Res; 1992 Mar; 574(1-2):42-8. PubMed ID: 1353403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrous oxide reverses the increase in striatal dopamine release produced by N-methyl-D-aspartate infusion in the substantia nigra pars compacta in rats.
    Balon N; Dupenloup L; Blanc F; Weiss M; Rostain JC
    Neurosci Lett; 2003 Jun; 343(2):147-9. PubMed ID: 12759185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol.
    Thanos PK; Jhamandas K; Beninger RJ
    Brain Res; 1992 Aug; 589(1):55-61. PubMed ID: 1422822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate.
    Turski L; Cavalheiro EA; Turski WA; Meldrum BS
    Neuroscience; 1986 May; 18(1):61-77. PubMed ID: 3016600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Chapman AG; Dürmuller N; Lees GJ; Meldrum BS
    Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro.
    Cherubini E; Herrling PL; Lanfumey L; Stanzione P
    J Physiol; 1988 Jun; 400():677-90. PubMed ID: 3047368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices.
    Crawford M; Roberts PJ
    Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study.
    Knauber J; Kischka U; Roth M; Schmidt WJ; Hennerici M; Fassbender K
    J Neural Transm (Vienna); 1999; 106(1):35-45. PubMed ID: 10195333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
    Clow DW; Jhamandas K
    J Pharmacol Exp Ther; 1989 Feb; 248(2):722-8. PubMed ID: 2563769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
    Henselmans JM; Hoogland PV; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.
    Rao TS; Cler JA; Mick SJ; Emmett MR; Farah JM; Contreras PC; Iyengar S; Wood PL
    J Neurochem; 1991 Mar; 56(3):907-13. PubMed ID: 1847188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.